
Jose Ricardo Perez
More content by Jose Ricardo Perez
Early Access Programmes: Challenges and Considerations
March 29 by Jose Ricardo PerezIn this Pharma IQ interview, Jose Ricardo Perez, Senior Medical Director at Novartis, highlights the biggest considerations for someone potentially looking at a new Early Access programme (EAP)...